{{Rsnum
|rsid=2868371
|Gene=HSPB1
|Chromosome=7
|position=76301442
|Orientation=minus
|GMAF=0.3122
|Gene_s=HSPB1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 4.5 | 41.4 | 54.1
| HCB | 29.9 | 54.7 | 15.3
| JPT | 23.9 | 58.4 | 17.7
| YRI | 0.0 | 22.4 | 77.6
| ASW | 3.5 | 17.5 | 78.9
| CHB | 29.9 | 54.7 | 15.3
| CHD | 39.8 | 49.1 | 11.1
| GIH | 6.0 | 45.0 | 49.0
| LWK | 0.0 | 10.9 | 89.1
| MEX | 15.8 | 47.4 | 36.8
| MKK | 0.0 | 12.2 | 87.8
| TSI | 9.8 | 33.3 | 56.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22608953
|Title=HSPB1 Gene Polymorphisms Predict Risk of Mortality for US Patients after Radio(chemo)therapy for Non-Small Cell Lung Cancer
|OA=1
}}

{{PMID Auto
|PMID=23374503
|Title=Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.
}}

{{on chip | Affy GenomeWide 6}}